Basic Information
| LncRNA/CircRNA Name | LINC00472 |
| Synonyms | LINC00472, C6orf155 |
| Region | GRCh38_6:71344344-71420769 |
| Ensemble | ENSG00000233237 |
| Refseq | NR_121612 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR |
| Sample | lung adenocarcinoma tissues |
| Expression Pattern | down-regulated |
| Function Description | lncRNAs LINC00472, and HCP5 were down-regulated in LAD tissues.a hub lncRNA LINC00472 functioned as a hub to compete with 12 mRNAs |
| Pubmed ID | 28793054 |
| Year | 2017 |
| Title | Revealing potential long non-coding RNA biomarkers in lung adenocarcinoma using long non-coding RNA-mediated competitive endogenous RNA network |
External Links
| Links for LINC00472 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |